13101

524394

VIMTALABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VIMTA LABS LIMITED Share Price Today

VIMTA LABS LIMITED is currently trading at ₹571.4, up by ₹4.3 from the previous close. The stock touched an intraday high of ₹578.00 and a low of ₹560.70 during the latest trading session. Over the past one year, VIMTA LABS LIMITED has delivered a return of 18.36%, while the stock has gained 26.1% in the last one month.

VIMTA LABS LIMITED performance

Today’s low Today’s high
₹ 560.70 ₹ 578.00
₹ 571.40
52 week low 52 week high
₹ 376.05 ₹ 902.65
₹ 571.40
Open Price ₹ 566.25
Prev. Close ₹ 567.10
Volume (Shares) 247219.00
Total traded value ₹ 1412.60
Upper Circuit ₹ 680.50
Lower Circuit ₹ 453.70
info

Investment Returns

Over 1 Month 26.10% Over 3 Months 36.43% Over 6 Months -5.78% Over 1 Year 18.36%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VIMTA LABS LIMITED fundamentals


  • Market cap (Cr) 2,552.40
  • P/E Ratio (TTM) 32.97
  • Beta 1.02
  • Book Value / share 102.27
  • Return on equity 18.55%
  • EPS (TTM) 17.65
  • Dividend yield 0.35%
  • Net profit/quarter (Cr) 21.11
info icon alternate text
  • Market cap (Cr) 2,554.90
  • P/E Ratio (TTM) 32.97
  • Beta 0.91
  • Book Value / share 102.27
  • Return on equity 18.55%
  • EPS (TTM) 17.65
  • Dividend yield 0.35%
  • Net profit/quarter (Cr) 21.11
info icon alternate text

VIMTA LABS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 109.25
Operating Expense 82.94
Net Profit 21.11
Net Profit Margin (%) 19.32
Earnings Per Share (EPS) 4.73
EBITDA 42.12
Effective Tax Rate (%) 27.29
Particulars DEC 2025 (Values in Cr)
Revenue 98.63
Operating Expense 75.47
Net Profit 17.59
Net Profit Margin (%) 17.83
Earnings Per Share (EPS) 3.96
EBITDA 34.45
Effective Tax Rate (%) 24.77
Particulars SEP 2025 (Values in Cr)
Revenue 101.85
Operating Expense 78.23
Net Profit 19.92
Net Profit Margin (%) 19.55
Earnings Per Share (EPS) 4.46
EBITDA 36.88
Effective Tax Rate (%) 24.17
Particulars JUN 2025 (Values in Cr)
Revenue 97.56
Operating Expense 74.05
Net Profit 18.89
Net Profit Margin (%) 19.36
Earnings Per Share (EPS) 4.25
EBITDA 35.44
Effective Tax Rate (%) 25.21
Particulars MAR 2025 (Values in Cr)
Revenue 94.44
Operating Expense 71.06
Net Profit 18.32
Net Profit Margin (%) 19.39
Earnings Per Share (EPS) 8.22
EBITDA 34.68
Effective Tax Rate (%) 26.80
Particulars MAR 2026 (Values in Cr)
Revenue 407.29
Operating Expense 310.71
Net Profit 77.51
Net Profit Margin (%) 19.03
Earnings Per Share (EPS) 17.40
EBITDA 148.89
Effective Tax Rate (%) 25.43
Particulars MAR 2025 (Values in Cr)
Revenue 343.98
Operating Expense 259.21
Net Profit 67.34
Net Profit Margin (%) 19.57
Earnings Per Share (EPS) 30.28
EBITDA 126.19
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 288.60
Operating Expense 229.79
Net Profit 41.01
Net Profit Margin (%) 14.20
Earnings Per Share (EPS) 18.52
EBITDA 97.74
Effective Tax Rate (%) 21.90
Particulars MAR 2023 (Values in Cr)
Revenue 315.12
Operating Expense 254.75
Net Profit 47.30
Net Profit Margin (%) 15.01
Earnings Per Share (EPS) 21.37
EBITDA 97.00
Effective Tax Rate (%) 25.89
Particulars MAR 2022 (Values in Cr)
Revenue 275.98
Operating Expense 220.87
Net Profit 41.06
Net Profit Margin (%) 14.87
Earnings Per Share (EPS) 18.57
EBITDA 80.01
Effective Tax Rate (%) 25.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 144.20
ROE % 13.64
ROCE % 16.99
Total Debt to Total Equity 0.06
EBITDA Margin 28.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 127.33
ROE % 18.68
ROCE % 23.48
Total Debt to Total Equity 0.07
EBITDA Margin 30.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.83
ROE % 19.30
ROCE % 22.76
Total Debt to Total Equity 0.12
EBITDA Margin 28.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 87.92
ROE % 11.66
ROCE % 13.58
Total Debt to Total Equity 0.17
EBITDA Margin 25.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.19
ROE % 3.96
ROCE % 5.58
Total Debt to Total Equity 0.19
EBITDA Margin 18.24
Particulars MAR 2026 (Values in Cr)
Book Value / Share 102.28
ROE % 18.55
ROCE % 23.21
Total Debt to Total Equity 0.01
EBITDA Margin 36.56
Particulars MAR 2025 (Values in Cr)
Book Value / Share 170.38
ROE % 19.44
ROCE % 24.14
Total Debt to Total Equity 0.04
EBITDA Margin 36.86
Particulars MAR 2024 (Values in Cr)
Book Value / Share 141.69
ROE % 13.66
ROCE % 19.43
Total Debt to Total Equity 0.06
EBITDA Margin 33.68
Particulars MAR 2023 (Values in Cr)
Book Value / Share 126.79
ROE % 18.40
ROCE % 23.15
Total Debt to Total Equity 0.07
EBITDA Margin 30.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.68
ROE % 19.19
ROCE % 22.69
Total Debt to Total Equity 0.11
EBITDA Margin 28.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.78
Total Assets 400.05
Total Liabilities 400.05
Total Equity 319.69
Share Outstanding 2
Price to Book Ratio 3.14
Return on Assets (%) 10.25
Return on Capital (%) 12.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 39.77
Total Assets 362.32
Total Liabilities 362.32
Total Equity 281.78
Share Outstanding 2
Price to Book Ratio 2.48
Return on Assets (%) 13.29
Return on Capital (%) 16.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.41
Total Assets 307.19
Total Liabilities 307.19
Total Equity 233.98
Share Outstanding 2
Price to Book Ratio 2.98
Return on Assets (%) 13.45
Return on Capital (%) 16.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.79
Total Assets 274.35
Total Liabilities 274.35
Total Equity 194.38
Share Outstanding 2
Price to Book Ratio 1.83
Return on Assets (%) 7.80
Return on Capital (%) 9.52
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.67
Total Assets 245.76
Total Liabilities 245.76
Total Equity 172.87
Share Outstanding 2
Price to Book Ratio 0.76
Return on Assets (%) 2.78
Return on Capital (%) 3.49
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 65.06
Total Assets 562.22
Total Liabilities 562.22
Total Equity 456.87
Share Outstanding 4
Price to Book Ratio 3.72
Return on Assets (%) 13.78
Return on Capital (%) 16.84
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 32.94
Total Assets 466.53
Total Liabilities 466.53
Total Equity 378.84
Share Outstanding 2
Price to Book Ratio 5.87
Return on Assets (%) 14.43
Return on Capital (%) 17.38
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.78
Total Assets 394.47
Total Liabilities 394.47
Total Equity 314.11
Share Outstanding 2
Price to Book Ratio 3.14
Return on Assets (%) 10.39
Return on Capital (%) 12.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 38.82
Total Assets 360.47
Total Liabilities 360.47
Total Equity 280.58
Share Outstanding 2
Price to Book Ratio 2.48
Return on Assets (%) 13.12
Return on Capital (%) 16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.27
Total Assets 306.23
Total Liabilities 306.23
Total Equity 233.64
Share Outstanding 2
Price to Book Ratio 2.98
Return on Assets (%) 13.40
Return on Capital (%) 16.25
Particulars MAR 2024 (Values in Cr)
Net Income 54.48
Cash from Operations 76.36
Cash from Investing -76.04
Cash from Financing -1.90
Net change in Cash -17.05
Free Cash Flow 152.69
Particulars MAR 2023 (Values in Cr)
Net Income 64.99
Cash from Operations 100.46
Cash from Investing -57.25
Cash from Financing -10.98
Net change in Cash 19.70
Free Cash Flow 148.28
Particulars MAR 2022 (Values in Cr)
Net Income 55.68
Cash from Operations 75.70
Cash from Investing -37.84
Cash from Financing -16.61
Net change in Cash 4.60
Free Cash Flow 105.49
Particulars MAR 2021 (Values in Cr)
Net Income 28.54
Cash from Operations 44.39
Cash from Investing -31.92
Cash from Financing -4.57
Net change in Cash 0.68
Free Cash Flow 77.47
Particulars MAR 2020 (Values in Cr)
Net Income 8.27
Cash from Operations 30.53
Cash from Investing -20.84
Cash from Financing -0.66
Net change in Cash 2.83
Free Cash Flow 46.33
Particulars MAR 2026 (Values in Cr)
Net Income 103.95
Cash from Operations 170.80
Cash from Investing -129.66
Cash from Financing -10.35
Net change in Cash 7.12
Free Cash Flow 270.48
Particulars MAR 2025 (Values in Cr)
Net Income 90.40
Cash from Operations 116.06
Cash from Investing -75.53
Cash from Financing -16.12
Net change in Cash 2.39
Free Cash Flow 195.13
Particulars MAR 2024 (Values in Cr)
Net Income 54.48
Cash from Operations 76.36
Cash from Investing -76.04
Cash from Financing -1.90
Net change in Cash -17.05
Free Cash Flow 152.69
Particulars MAR 2023 (Values in Cr)
Net Income 63.83
Cash from Operations 98.74
Cash from Investing -56.92
Cash from Financing -10.66
Net change in Cash 18.92
Free Cash Flow 146.52
Particulars MAR 2022 (Values in Cr)
Net Income 55.34
Cash from Operations 75.24
Cash from Investing -37.88
Cash from Financing -16.14
Net change in Cash 4.64
Free Cash Flow 104.96
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 62.45 12.89 122170.95 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.22 23.63 2.85 97.87 40.75 76.00
SHREE PACETRONIX LTD. 134.30 16.03 2.82 50.36 66.10 283.15
TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 81.38 12.26 122170.95 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.25 0.00 -9.55 29.32 30.30 57.48
KOVAI MEDICAL CENTER & HO 5834.80 26.11 4.83 6383.27 5010.00 6725.00

VIMTA LABS LIMITED shareholding pattern

Holding
59.12%
35.85%
4.89%
0.13%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

VIMTA LABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
571.40 0.75 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 555.90
  • 26 Days 512.60
  • 10 Days 542.10
  • 50 Days 494.70
  • 12 Days 537.10
  • 100 Days 496.70
  • 20 Days 521.20
  • 200 Days 512.40
568.63 PIVOT
First Support 541.27 First Resistance 594.47 Second Support 515.43 Second Resistance 621.83 Third Support 488.07 Third Resistance 647.67
RSI 70.19 ADX 53.22 MACD 24.49 Williams % R -17.03 Commodity Channel Index (CCI) 110.54
Date 2026-06-19 Week 148598.00 Same Day 78518.00 Month 105447.00
1 Year 1.03 3 Year 0.94
Over 1 Month
26.10% down
Over 1 Year
18.36% down
Over 3 Months
36.43% down
Over 3 Years
41.03% down
Over 6 Months
-5.78% down
Over 5 Years
35.27% down

VIMTA LABS LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Jun 2026 2.0 Final 18 Jun 2026 Equity shares
30 May 2025 2.0 Final 30 May 2025 Equity shares
11 Jul 2024 2.0 Final 12 Jul 2024 Equity shares
21 Jun 2023 2.0 Final 22 Jun 2023 Equity shares
16 Jun 2022 2.0 Final 18 Jun 2022 Equity shares
25 Jun 2021 2.0 Final 28 Jun 2021 Equity shares
18 Jul 2019 2.0 Final 22 Jul 2019 Equity shares
14 Aug 2018 2.0 Final 20 Aug 2018 Equity shares
25 Aug 2016 1.0 Final 29 Aug 2016 Equity shares
06 Aug 2015 1.0 Final 10 Aug 2015 Equity shares
27 Jun 2014 2.0 Final 01 Jul 2014 Equity shares
23 May 2013 0.6 Final 27 May 2013 Equity shares
15 Sep 2011 0.4 Final 19 Sep 2011 Equity shares
23 Sep 2010 0.8 Final 27 Sep 2010 Equity shares
10 Sep 2009 0.8 Final 14 Sep 2009 Equity shares
28 Aug 2008 0.8 Final 01 Sep 2008 Equity shares
02 Aug 2007 0.8 Final 06 Aug 2007 Equity shares
01 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
19 May 2005 0.0 Final 23 May 2005 Equity shares
Ex-Date Ex-Bonus Ratio
13 Jun 2025 13 Jun 2025 1:1
Ex-Date Old FV NEW FV Record Date
24 Feb 2006 10.0 2.0 03 Mar 2006
Dividend date Dividend amount Dividend type Record date Instrument type
18 Jun 2026 2.0 Final 18 Jun 2026 Equity shares
30 May 2025 2.0 Final 30 May 2025 Equity shares
11 Jul 2024 2.0 Final 12 Jul 2024 Equity shares
21 Jun 2023 2.0 Final 22 Jun 2023 Equity shares
16 Jun 2022 2.0 Final 18 Jun 2022 Equity shares
25 Jun 2021 2.0 Final 28 Jun 2021 Equity shares
18 Jul 2019 2.0 Final 22 Jul 2019 Equity shares
14 Aug 2018 2.0 Final 20 Aug 2018 Equity shares
25 Aug 2016 1.0 Final 29 Aug 2016 Equity shares
06 Aug 2015 1.0 Final 10 Aug 2015 Equity shares
27 Jun 2014 2.0 Final 01 Jul 2014 Equity shares
23 May 2013 0.6 Final 27 May 2013 Equity shares
15 Sep 2011 0.4 Final 19 Sep 2011 Equity shares
23 Sep 2010 0.8 Final 27 Sep 2010 Equity shares
10 Sep 2009 0.8 Final 14 Sep 2009 Equity shares
28 Aug 2008 0.8 Final 01 Sep 2008 Equity shares
02 Aug 2007 0.8 Final 06 Aug 2007 Equity shares
01 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
19 May 2005 0.0 Final 23 May 2005 Equity shares
Ex-Date Ex-Bonus Ratio
13 Jun 2025 13 Jun 2025 1:1
Ex-Date Old FV NEW FV Record Date
24 Feb 2006 10.0 2.0 03 Mar 2006

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vimta Labs Ltd?

Answer Field

Vimta Labs Ltd share price is for NSE ₹ 571.40 & for BSE ₹ 572.15 as on Jun 19 2026 03:30 PM.

What is the Market Cap of Vimta Labs Ltd Share?

Answer Field

The market cap of Vimta Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 19 2026 03:30 PM.

What is the 52 Week High and Low of Vimta Labs Ltd?

Answer Field

The 52 Week High and Low of Vimta Labs Ltd for NSE is ₹ 902.65 and ₹ 376.05 and for BSE is ₹ 902.85 and ₹ 377.30.

What is 1 year return for Vimta Labs Ltd?

Answer Field

The 1 year returns on the stock has been 18.36%.

What is the P/E Ratio of Vimta Labs Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM the price-to-earnings (PE) ratio for Vimta Labs Ltd share is 32.97.

What is the PB ratio of Vimta Labs Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM, the price-to-book (PB) ratio for Vimta Labs Ltd share is 102.27.

How to Buy Vimta Labs Ltd Share?

Answer Field

You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vimta Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Vimta Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vimta Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|